Literature DB >> 17067661

Reduced Cd4+Cd25+ T cells in patients with idiopathic thrombocytopenic purpura.

Miho Sakakura1, Hideo Wada, Isao Tawara, Tsutomu Nobori, Takashi Sugiyama, Norimasa Sagawa, Hiroshi Shiku.   

Abstract

Immunoregulatory CD4(+)CD25(+) T cells play an important role in the induction and maintenance of peripheral self-tolerance. These professional regulatory cells prevent the activation and proliferation of potentially autoreactive T cells that have escaped thymic deletion. Therefore, CD4(+)CD25(+) T cells are believed to possibly play an important role in pathogenic autoimmune diseases. We measured the count of CD4(+)CD25(+) T cells in 44 patients with idiopathic thrombocytopenic purpura (ITP), and the number of CD4(+)CD25(+) T cells and clinical features were then analyzed. By using a flow cytometric analysis, the number of CD4(+)CD25(+) T cells in the patients with ITP showed a very wide distribution in comparison to healthy volunteers. The number of CD4(+)CD25(+) T cells was significantly lower in the ITP patients in the severe phase, and in patients positive for anti-glycoprotein IIb-IIIa antibody. However, the number of those cells increased in the patients at the complete remission phase, especially after a splenectomy. The Foxp3 mRNA levels of peripheral blood mononuclear cells (PBMC) of ITP patients were higher with an improved platelet count than in those with a low platelet count. In addition, the Foxp3 mRNA levels closely correlated with the number of CD4(+)CD25(+) cells. These mechanisms remain to be fully elucidated, however, the count of CD4(+)CD25(+) T cells is considered to possibly be related to the severity of ITP.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17067661     DOI: 10.1016/j.thromres.2006.09.008

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  41 in total

Review 1.  Piecing together the humoral and cellular mechanisms of immune thrombocytopenia.

Authors:  Lisa J Toltl; Ishac Nazi; Reza Jafari; Donald M Arnold
Journal:  Semin Thromb Hemost       Date:  2011-11-18       Impact factor: 4.180

Review 2.  Advances in immunopathogenesis of adult immune thrombocytopenia.

Authors:  Xinguang Liu; Yu Hou; Jun Peng
Journal:  Front Med       Date:  2013-11-21       Impact factor: 4.592

3.  Elevated profile of Th17, Th1 and Tc1 cells in patients with immune thrombocytopenic purpura.

Authors:  Jingbo Zhang; Daoxin Ma; Xiaojuan Zhu; Xun Qu; Chunyan Ji; Ming Hou
Journal:  Haematologica       Date:  2009-09       Impact factor: 9.941

4.  Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpura.

Authors:  Jin Yu; Susanne Heck; Vivek Patel; Jared Levan; Yu Yu; James B Bussel; Karina Yazdanbakhsh
Journal:  Blood       Date:  2008-04-17       Impact factor: 22.113

5.  Skewed T-cell subsets and enhanced macrophages phagocytosis in the spleen of patients with immune thrombocytopenia failing glucocorticoids.

Authors:  Xiaodong Chen; Sirui Chen; Chunlin Li; Yankun Zhu; Bing Peng
Journal:  Int J Hematol       Date:  2011-08-20       Impact factor: 2.490

6.  Eltrombopag therapy in newly diagnosed steroid non-responsive ITP patients.

Authors:  Anil Kumar Tripathi; Ayush Shukla; Sanjay Mishra; Yogendra Singh Yadav; Deependra Kumar Yadav
Journal:  Int J Hematol       Date:  2014-02-14       Impact factor: 2.490

Review 7.  Interleukin-35: a Potential Therapeutic Agent for Autoimmune Diseases.

Authors:  Shi-Yang Guan; Rui-Xue Leng; Muhammad Imran Khan; Humera Qureshi; Xiang-Pei Li; Dong-Qing Ye; Hai-Feng Pan
Journal:  Inflammation       Date:  2017-02       Impact factor: 4.092

8.  Inactivation of Notch signaling reverses the Th17/Treg imbalance in cells from patients with immune thrombocytopenia.

Authors:  Shuang Yu; Chuanfang Liu; Lanhua Li; Tian Tian; Min Wang; Yu Hu; Cunzhong Yuan; Lei Zhang; Chunyan Ji; Daoxin Ma
Journal:  Lab Invest       Date:  2014-12-08       Impact factor: 5.662

9.  Selective expression of latency-associated peptide (LAP) and IL-1 receptor type I/II (CD121a/CD121b) on activated human FOXP3+ regulatory T cells allows for their purification from expansion cultures.

Authors:  Dat Q Tran; John Andersson; Donna Hardwick; Lolita Bebris; Gabor G Illei; Ethan M Shevach
Journal:  Blood       Date:  2009-03-18       Impact factor: 22.113

10.  Alterations in immune cell subsets and their cytokine secretion profile in childhood idiopathic thrombocytopenic purpura (ITP).

Authors:  R M Talaat; A M Elmaghraby; S S Barakat; M El-Shahat
Journal:  Clin Exp Immunol       Date:  2014-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.